Evidence map›Paper›PMID 41329646›Full record

ArticlePLoS medicine2025

Hospital-based care for hallucinogens and risk of mania and bipolar disorder: A population-based cohort study.

Daniel T Myran, Rachael MacDonald-Spracklin, Michael Pugliese, Maya Gibb, Jess G Fiedorowicz, Tyler S Kaster, Marco Solmi

Abstract read
In one paragraph

Article in PLoS medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distribution.Canadian journal of public health = Revue canadienne de sante publique · 2026
    Article
  4. Review
  5. Psychedelic-Related Psychosis: From Model Psychosis to Psychotherapy.Current topics in behavioral neurosciences · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Daniel T MyranDepartment of Family and Community Medicine, North York General Hospital, Toronto, Canada.ORCID https://orcid.org/0000-0002-8038-300X
Rachael MacDonald-SpracklinBruyère Health Research Institute, Ottawa, Ontario, Canada.ORCID https://orcid.org/0000-0002-2016-3232
Michael PuglieseICES uOttawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Maya GibbOttawa Hospital Research Institute, Ottawa, Ontario, Canada.
Jess G FiedorowiczOttawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID https://orcid.org/0000-0003-2057-4071
Tyler S KasterDepartment of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-5299-4794
Marco SolmiSchool of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada.ORCID https://orcid.org/0000-0003-4877-7233

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHallucinogen use for both recreational and medical purposes is rapidly increasing globally, raising concerns about potential adverse effects. This study examined the risk of incident mania or bipolar disorder (BD) diagnosis associated with having an emergency department (ED) visit or hospitalization involving hallucinogens. METHODS AND

findingsWe used a population-based cohort study of all individuals aged 14-65 years with no baseline history of BD and registered in the Ontario Health Insurance Plan in Ontario, Canada, between 2008-2022. Incident mania (primary outcome) and incident BD (secondary outcome) were compared between individuals with acute care (an ED visit or hospitalization) involving hallucinogens and the general population using overlap propensity score weighted Cox proportional hazard models. Models were adjusted for age, sex, rural residence, income quintile, recent documentation of homelessness, and healthcare encounters for mental health or other substance use in the past five years. The study included 9,311,844 individuals of which 7,285 (0.08%) had acute care involving hallucinogens. Within 3-years of acute care involving hallucinogens, 1.43% (n = 104) of individuals had an incident episode of mania requiring acute care compared to 0.06% (n = 41) of individuals in the age-sex matched general population, a 25-fold increase in risk. After weighting, acute care for hallucinogens was associated with a 6-fold (weighted Hazard Ratio [HR] 5.97, 95% CI 3.29, 10.82) increase in risk of incident mania relative to individuals without hallucinogen acute care who had otherwise similar demographic and mental health histories. Associated increases were also observed for risk of an incident diagnosis of BD (HR 3.75 95%CI 2.49, 5.65, absolute proportion 2.50% versus 0.11%). The main limitation of the study is the risk associated with the exposure examined in this study may not generalize to the majority of people who use hallucinogens who do not require acute care.

conclusionsThese findings suggest the need for ongoing caution regarding hallucinogen use in individuals at risk of bipolar disorder. They also have potential implications for clinical practice, research, and public health policy, including substance regulation and targeted education for high-risk groups in the context of rising hallucinogen use.

Indexed as

Bipolar DisorderEmergency Service, HospitalHallucinogensHospitalizationManiaAdolescentAdultAgedCohort StudiesFemaleHumansIncidenceMaleMiddle AgedOntarioRisk FactorsHallucinogens

Identifiers

PMID41329646
PMCPMC12671790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.